Candidiasis Crónica

Volver al artículo.

Referencias para el artículo

  1. Truss CO. The role of Candida albicans in human illness. J Orthomol Psychiatry 1981,10:228–38 [review].
  2. Crook WG. The Yeast Connection, 2nd ed. Jackson, TN: Professional Books, 1984, 1–2 [review].
  3. Kroker GF. Chronic candidiasis and allergy. In: Brostoff J, Challacombe SJ (eds). Food Allergy and Intolerance. Philadelphia, PA: WB Saunders, 1987, 850–72 [review].
  4. Bauman DS, Hagglund HE. Correlation between certain polysystem chronic complaints and an enzyme immunoassay with antigens of Candida albicans. J Advancement Med 1991;4:5–19.
  5. Bennett JE. Candidiasis. In: Fauci AS, Braunwald E, Isselbacher KJ, et al (eds). Harrison’s Principles of Internal Medicine New York: McGraw-Hill, 1998.
  6. Horowitz BJ, Edelstein S, Lippman L. Sugar chromatography studies in recurrent Candida vulvovaginitis. J Reprod Med 1984;29:441–3.
  7. Weig M, Werner E, Frosch M, Kasper H. Limited effect of refined carbohydrate dietary supplementation on colonization of the gastrointestinal tract of healthy subjects by Candida albicans. Am J Clin Nutr 1999;69:1170–3.
  8. Collins EB, Hardt P. Inhibition of Candida albicans by Lactobacillus acidophilus. J Dairy Sci 1980;63:830–2.
  9. Fitzsimmons N, Berry DR. Inhibition of Candida albicans by Lactobacillus acidophilus: evidence for the involvement of a peroxidase system. Microbios 1994;80:125–33.
  10. Wagner RD, Pierson C, Warner T, et al. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 1997;65(10):4165–72.
  11. Keeney EL. Sodium caprylate: a new and effective treatment of moniliasis of the skin and mucous membrane. Bull Johns Hopkins Hosp 1946;78:333–9.
  12. Neuhauser I, Gustus EL. Successful treatment of intestinal moniliasis with fatty acid resin complex. Arch Intern Med 1954;93:53–60.
  13. Boero M, Pera A, Andriulli A, et al. Candida overgrowth in gastric juice of peptic ulcer subjects on short- and long-term treatment with H2-receptor antagonists. Digestion 1983;28:158–63.
  14. Rubinstein E. Antibacterial activity of the pancreatic fluid. Gastroenterology 1985;88:927–32 [review].
  15. Sarker SA, Gyr R. Non-immunological defense mechanisms of the gut. Gut 1990;33:1331–7 [review].
  16. Truss CO. The role of Candida albicans in human illness. J Orthomol Psychiatry 1981,10:228–38 [review].
  17. Moore GS, Atkins RD. The fungicidal and fungistatic effects of an aqueous garlic extract on medically important yeast-like fungi. Mycologia 1977;69:341–8.
  18. Sandhu DK, Warraich MK, Singh S. Sensitivity of yeasts isolated from cases of vaginitis to aqueous extracts of garlic. Mykosen 1980;23:691–8.
  19. Prasad G, Sharma VD. Efficacy of garlic (Allium sativum) treatment against experimental candidiasis in chicks. Br Vet J 1980;136:448–51.
  20. Arora DS, Kaur J. Anti-microbial activity of spices. Int J Antimicrob Agents 1999;12:257–62.
  21. Hammer KA, Carson CF, Riley TV. In-vitro activity of essential oils, in particular Melaleuca alternafolia (tea tree) oil and tea tree oil products, against Candida albicans. J Antimicrobial Chemother 1998;42:591–5.
  22. Stiles JC. The inhibition of Candida albicans by oregano. J Applied Nutr 1995;47:96–102.
  23. Hahn FE, Ciak J. Berberine. Antibiotics 1976;3:577–88 [review].
  24. Majahan VM, Sharma A, Rattan A. Antimycotic activity of berberine sulphate: an alkaloid from an Indian medicinal herb. Sabouraudia 1982;20:79–81.
  25. Bhakat MP. Therapeutic trial of Berberine sulphate in non-specific gastroenteritis. Indian Med J 1974;68:19–23.
  26. Kamat SA. Clinical trial with berberine hydrochloride for the control of diarrhoea in acute gastroenteritis. J Assoc Physicians India 1967;15:525–9.
  27. Desai AB, Shah KM, Shah DM. Berberine in the treatment of diarrhoea. Indian Pediatr 1971;8:462–5.
  28. Coeugniet EG, Kuhnast R. Recurrent candidiasis: adjuvant immunotherapy with different formulations of Echinacin®. Therapiewoche 1986;36:3352–8.